NIH-funded research R01 grant

Alveolar surface protection in women with ARDS

Official title: Alveolar epithelial glycocalyx resilience in women during ARDS

Funded at Massachusetts General Hospital · NIH-11387458 · Data updated 2026-11-12

This grant tests how female biology affects lung lining protection in severe lung failure (ARDS) to guide more targeted therapies.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 21, 2025
Project endJune 30, 2030
Funding year2026
Award (this year)$725,444
NIH project number5R01HL179324-02
Project IDNIH-11387458 on NIH RePORTER

Who could benefit from this research

Could help

Adults with ARDS or those at risk due to severe lung injury, particularly women, may be eligible for future studies or subsequent trials.

Less likely to help

Most patients with ARDS unrelated to the study’s specific mechanisms or who are not eligible due to safety criteria may not benefit.

What this research studies

In ARDS, the lung’s protective surface layer can break down, leading to worsened breathing. This project focuses on how sex differences influence this process, especially in women, by studying lung fluid and donor lung tissue to understand glycocalyx resilience. Researchers will analyze samples from patients on mechanical ventilation and compare them with healthy controls to identify protective factors like SLPI. The aim is to move toward precision treatments that consider a patient’s sex and specific lung injury mechanisms.

Why it matters

Potential benefit: If successful, the work could lead to sex-informed strategies to preserve lung lining and improve outcomes for patients with ARDS.

How similar studies have gone: Preliminary data suggest sex differences in ARDS biology; this study builds on those findings to translate them into targeted approaches.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Schmidt, Eric Peter — Massachusetts General Hospital
  • Study coordinator: Schmidt, Eric Peter

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.